Clinical Trial Update: A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency [Phase 2, Phase 3]

View source ↗

Summary

The document reports an ongoing Phase 2/Phase 3 clinical trial of VGN-R09b for Aromatic L-amino Acid Decarboxylase Deficiency, with the study currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aromatic L-amino Acid Decarboxylase Deficiency

Drugs mentioned

• VGN-R09b

Snippet

Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. | Conditions: Aromatic L-amino Acid Decarboxylase Deficiency | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING